Cargando…
Tumor Regression and Cure Depends on Sustained Th1 Responses
While immunomodulatory monoclonal antibodies (mAbs) have therapeutic efficacy against many tumors, few patients are cured. Attempting to improve their therapeutic efficacy we have applied the TC1 mouse lung carcinoma model and injected established subcutaneous tumors intratumorally with 3 weekly dos...
Autores principales: | Dai, Min, Hellstrom, Ingegerd, Yip, Yuen Y., Sjögren, Hans Olov, Hellstrom, Karl Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133214/ https://www.ncbi.nlm.nih.gov/pubmed/29912725 http://dx.doi.org/10.1097/CJI.0000000000000231 |
Ejemplares similares
-
IN VITRO DEMONSTRATION OF HUMORAL AND CELL-BOUND IMMUNITY AGAINST COMMON SPECIFIC TRANSPLANTATION ANTIGEN(S) OF ADENOVIRUS 12-INDUCED MOUSE AND HAMSTER TUMORS
por: Hellström, Ingegerd, et al.
Publicado: (1967) -
Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy
por: Wei, Huafeng, et al.
Publicado: (2014) -
Human and Mouse CD137 Have Predominantly Different Binding CRDs to Their Respective Ligands
por: Yi, Ling, et al.
Publicado: (2014) -
No association between the aluminium content of trabecular bone and bone density, mass or size of the proximal femur in elderly men and women
por: Hellström, Hans-Olov, et al.
Publicado: (2006) -
Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis
por: Zhu, Ran-Xu, et al.
Publicado: (2019)